Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
trading-ideas

1 min read • August 31, 2018
Other Cannabis Stocks Rebounding From Morning Lows As Canopy Growth CEO Is Currently Speaking On CNBC: Cronos Group Shares Up 1.3%, Tillray Shares Up 0.7%

3 min read • August 30, 2018
Cronos Group Plummets After Citron Calls It The ‘Dark Side Of Cannabis’

1 min read • August 30, 2018
Cannabis Stocks Selling Off Notably Over Last Few Mins: Cronos Group Shares Down 8%, Tillray Down 2.5%, Canopy Growth Down 1.3%

1 min read • August 30, 2018
Therapix Biosciences shares are up 13.7%; Until Thursday morning, shares of the nano-cap cannabis-based pharmaceutical company have been unchanged as cannabis stocks rallied over past two weeks.

1 min read • August 30, 2018
Marijuana Stocks Appear Unaffected Amid Comment From Long-Known Cannabis Proponent, Vincente Fox, Former President Of Mexico: ‘Marijuana Should Be Part Of NAFTA’

1 min read • August 30, 2018
OTC Cannabis-Related Stock CV Sciences Up 25% Thurs.; Co. Earlier Issued Press Release Highlighting ‘we are keenly aware of recent market activity and certain disinformation disseminated by persons holding short positions in our stock’

2 min read • August 30, 2018
The Marijuana ETF Is Lighting It Up As Investors Are Buying In

2 min read • August 29, 2018
Tilray’s First Earnings Print Gives Cannabis Stocks Another Boost

1 min read • August 29, 2018
‘Citron covering $CVSI short. Making 70% in a week is always a good trade. Stay tuned for more cannabis trades, our team is working hard to bring you the next 70% return.’-Citron Research Tweets

1 min read • August 29, 2018
Shares of nano-cap cannabis stock India Globalization Capital are trading up 36.4% premarket; Despite no company-specific news, the stock may be spiking in sympathy with Tilray following Q2 results.

3 min read • August 27, 2018
Cannabis Stocks Remain Hot, But Might Be Getting Overheated

1 min read • August 27, 2018
420 Investor’s Alan Brochstein, On Recent Bull Run In Cannabis Stocks, Tells Benzinga Tilray, Cronos & Canopy Growth Benefit Disproportionately From U.S. Listing Status, Adds Those Cos. ‘Seem expensive to me. Tilray, especially, with its very tight float’
Latest Headlines
View All
5 min read • June 3, 2026
The Biggest Compliance Risk In Cannabis Might Already Be Inside Your Company
2 min read • June 3, 2026
This Cannabis Co. Hands Over Core US Assets To Lender-Backed Entity After Restructuring Agreement
6 min read • June 3, 2026
The Celebrity Cannabis Boom Became A Graveyard. The Survivors Had Four Things In Common
2 min read • June 2, 2026
Vireo Growth Reshapes Share Structure After Major Expansion Transactions
2 min read • June 2, 2026
Cannabis Giant, Verano, Joins Industry Peers In Reverse Stock Split Trend With 1-For-5 Consolidation
7 min read • June 2, 2026
Cannabis M&A Is Back, But Not The Way Investors Expected
4 min read • June 2, 2026
EXCLUSIVE: Virginia Governor Defends Cannabis Veto, Citing Timeline And Licensing Concerns
2 min read • June 1, 2026
Five-Month Hemp Enforcement Grace Period Ends In Oregon, Here’s What Businesses Must Know
3 min read • June 1, 2026
New Tennessee Hemp Rules Threaten THCa Market And Millions Of Dollars In Sales
3 min read • June 1, 2026
Robinhood Opens The Door To U.S. Cannabis Stocks
4 min read • June 1, 2026
Fireman Entrepreneur Award Builds Momentum Ahead of 2026 Announcement in Chicago
4 min read • June 1, 2026
Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis earnings
cannabis farms
cannabis study
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
Hot
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.
